West Family Investments Inc. increased its position in Stryker Corporation (NYSE:SYK) by 3.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 125,220 shares of the medical technology company’s stock after acquiring an additional 4,000 shares during the period. Stryker Corporation makes up 3.6% of West Family Investments Inc.’s portfolio, making the stock its 6th biggest position. West Family Investments Inc.’s holdings in Stryker Corporation were worth $16,628,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Lockheed Martin Investment Management Co. acquired a new stake in shares of Stryker Corporation in the 2nd quarter worth about $1,249,000. JPMorgan Chase & Co. increased its holdings in shares of Stryker Corporation by 276.9% in the 1st quarter. JPMorgan Chase & Co. now owns 269,555 shares of the medical technology company’s stock worth $35,487,000 after acquiring an additional 198,035 shares during the period. BB&T Corp increased its holdings in shares of Stryker Corporation by 5.7% in the 2nd quarter. BB&T Corp now owns 56,546 shares of the medical technology company’s stock worth $7,847,000 after acquiring an additional 3,060 shares during the period. British Columbia Investment Management Corp increased its holdings in shares of Stryker Corporation by 10.7% in the 1st quarter. British Columbia Investment Management Corp now owns 133,596 shares of the medical technology company’s stock worth $17,588,000 after acquiring an additional 12,871 shares during the period. Finally, Hartland & Co. LLC increased its holdings in shares of Stryker Corporation by 1.4% in the 1st quarter. Hartland & Co. LLC now owns 1,860 shares of the medical technology company’s stock worth $245,000 after acquiring an additional 25 shares during the period. 74.18% of the stock is currently owned by institutional investors and hedge funds.

In other news, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the sale, the insider now directly owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The disclosure for this sale can be found here. Insiders have sold a total of 25,429 shares of company stock valued at $3,686,927 over the last three months. Company insiders own 7.40% of the company’s stock.

Stryker Corporation (SYK) opened at 143.03 on Thursday. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84. The firm has a market capitalization of $53.50 billion, a PE ratio of 31.93 and a beta of 0.81. The firm has a 50 day moving average of $143.90 and a 200 day moving average of $138.47.

Stryker Corporation (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.39 EPS. Equities analysts forecast that Stryker Corporation will post $6.46 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.19%. Stryker Corporation’s dividend payout ratio is currently 37.95%.

A number of analysts recently weighed in on SYK shares. Morgan Stanley increased their price objective on shares of Stryker Corporation from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Wednesday, June 21st. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $155.00 price objective on shares of Stryker Corporation in a report on Friday, September 1st. Cantor Fitzgerald started coverage on shares of Stryker Corporation in a report on Thursday, June 29th. They issued a “neutral” rating and a $153.00 price objective on the stock. BidaskClub cut shares of Stryker Corporation from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Finally, Zacks Investment Research raised shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price objective on the stock in a report on Monday, July 17th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the stock. Stryker Corporation currently has an average rating of “Hold” and an average price target of $145.73.

WARNING: “Stryker Corporation (SYK) Shares Bought by West Family Investments Inc.” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/09/14/stryker-corporation-syk-shares-bought-by-west-family-investments-inc.html.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.